Makoto Suzuki

Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer

Y. Tomita, Koei Ikeda, T. Sakagami, 2022, International journal of molecular sciences.

Heterogeneous expression and role of receptor tyrosine kinase-like orphan receptor 2 (ROR2) in small cell lung cancer

K. Fujino, S. Kudoh, M. Sanada, 2022, Human Cell.

Onionin A inhibits small-cell lung cancer proliferation through suppressing STAT3 activation induced by macrophages-derived IL-6 and cell–cell interaction with tumor-associated macrophage

T. Nohara, Yukio Fujiwara, T. Ikeda, 2023, Human Cell.

The Significance of SPP1 in Lung Cancers and Its Impact as a Marker for Protumor Tumor-Associated Macrophages

D. Kurotaki, Y. Komohara, Yusuke Shinchi, 2023, Cancers.

Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters

H. Machiyama, E. Wakamatsu, M. Azuma, 2023, Nature communications.

PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma

Koei Ikeda, Y. Komohara, C. Pan, 2023, Medical Molecular Morphology.

Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma.

T. Sakagami, Eri Matsubara, Kazuchika Nishitsuji, 2024, Cancer science.

Distinct functions between ferrous and ferric iron in lung cancer cell growth

Koei Ikeda, T. Moroishi, Mayumi Niimura, 2023, Cancer science.